Skip to content

OnKure Therapeutics, Inc.

OKUR

CIK 0001637715

← back to feed
Revenue (TTM)
$0
Q1 May 2026
Net Income (TTM)
−$58.75M
−13.0% YoY Q1 May 2026
EPS Diluted (TTM)
−$4.53
+71.2% YoY Q1 May 2026
Gross Margin
—
Q1 May 2026
Operating Margin
—
Q1 May 2026
Net Margin
—
Q1 May 2026
Free Cash Flow (TTM)
−$46.82M
Q1 May 2026
Cash
$192.11M
Q1 May 2026
Total Debt
—
Q1 May 2026
Shares Outstanding
40.4M sh
Q1 May 2026

Revenue & Net Income

EPS (Diluted)

Cash Flow

Revenue Growth (YoY)

No data available for this metric.

Balance Sheet

Cash vs Debt

Recent filings